Altria Group shares rise as cigarette volume decline outperforms expectations and peers
Updated
Updated · The Motley Fool · Apr 28
Altria Group shares rise as cigarette volume decline outperforms expectations and peers
9 articles · Updated · The Motley Fool · Apr 28
Barclays data shows Altria's cigarette volumes fell 4.7% in four weeks to April 18, outperforming British American Tobacco and Imperial Brands, whose declines exceeded 9%.
Overall U.S. cigarette volumes dropped 5.1% year-over-year, less than Barclays' estimated 7.3% decline, boosting Altria's share price by nearly 3%.
While traditional tobacco sales continue to shrink, nicotine pouches saw 22% growth and e-cigarette sales fell 17%, highlighting shifting consumer preferences and challenges for industry players.
Can Altria's high dividend survive the slow death of cigarettes and its battle for relevance in the smoke-free market?
Philip Morris's ZYN controls the pouch market. Can Altria's new leadership and 'on! PLUS' product actually compete?
As cigarette sales decline, how will states manage budget shortfalls while also regulating the explosive growth of new nicotine products?
Is Altria's stock rally a sign of true strength, or is it just the best house in a neighborhood facing demolition?
Why are consumers rapidly abandoning vaping for nicotine pouches, and what does this reveal about the future of nicotine addiction?